First clinical trial of embryonic stem cell therapy gets go-ahead

Sunday 1 August 2010

Geron Corporation said it has received clearance from the Food and Drug Administration to proceed with a human trial of an embryonic stem cell-based therapy in patients with acute spinal cord injury.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States